Koyasu Sho

Research field (2)： Radiology , Tumor biology

Research theme for competitive and other funds (9)：

2022 - 2025 網羅的遺伝子スクリーニング技術を用いた甲状腺癌内用療法に対する抵抗性因子の探索
2020 - 2023 Exploration of Companion Diagnosis and Personalized Medicine of Tumor Using Chemokine Receptor Imaging
2019 - 2022 Development of Nuclear Medicine Imaging Techniques for Personalized Medicine Focusing on Metabolic Changes in Glioblastoma
2018 - 2021 Mechanism of Action and Function of a novel HIF-1 activator in p53-deficient cancers
2017 - 2020 癌細胞の低酸素応答と放射線抵抗性を担う新規遺伝子の機能解析と治療・画像化への展開

Show all

Papers (82)：

Gouki Kambe, Minoru Kobayashi, Hiroshi Ishikita, Sho Koyasu, Ester M. Hammond, Hiroshi Harada. ZBTB7A forms a heterodimer with ZBTB2 and inhibits ZBTB2 homodimerization required for full activation of HIF-1. Biochemical and Biophysical Research Communications. 2024. 733. 150604-150604
Sho Koyasu, Akihiko Sugimoto, Junichi Matsubara, Manabu Muto, Yuji Nakamoto. SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder. Clinical Nuclear Medicine. 2024
Toshiya Takamura, Sho Koyasu, Akihiko Sugimoto, Takayuki Yamamoto, Yuji Nakamoto. Hyalinizing Clear Cell Carcinoma in the Sphenoid Sinus. Clinical nuclear medicine. 2024. 49. 3. 287-288
Hiroki Tanaka, Sho Koyasu, Masahiro Kikuchi, Mami Iima, Koichi Omori, Yuji Nakamoto. Utility of Diffusion-weighted MR Imaging for Evaluating the Depth of Invasion in Oral Tongue Squamous Cell Carcinoma. Magnetic Resonance in Medical Sciences. 2024
Yukari SHIRAI, Tatsuya SUWA, Minoru KOBAYASHI, Sho KOYASU, Hiroshi HARADA. DDX5 enhances HIF-1 activity by promoting the interaction of HIF-1α with HIF-1β and recruiting the resulting heterodimer to its target gene loci. Biology of the Cell. 2023

ｍore...

MISC (38)：

Yoshito Yamada, Masatsugu Hamaji, Harutaro Okada, Akihiro Takahagi, Hitomi Ajimizu, Sho Koyasu, Yuichi Sakamori, Akihiro Aoyama. Re-evaluation and operative indications after induction therapy for thymic epithelial tumors. Mediastinum. 2024. 8
野橋智美, 中本隆介, 坂本亮, 八上全弘, 子安翔, 三宅可奈江, 磯田裕義, 中本裕士. FDG-PET検査前に低血糖が発覚した際の糖付与によるPET画質への影響について. 核医学(Web). 2023. 60. Supplement
子安翔, 志水陽一, 中本裕士. ⁶⁸Ga-DOTATOC PET/CT for Diagnosing Neuroendocrine Tumors. 癌と化学療法. 2022. 49. 8
Sho Koyasu, Yoichi Shimizu, Mari Suzukida, Takero Shindo, Masahiro Ono, Yuji Nakamoto. Development of a novel radiotracer for imaging T cell lymphoma: In-111-DTPA-Mogamulizumab. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
西尾瑞穂, 子安翔, 中本裕士. 肺癌予後予測のためのElastic Netを用いたFDG-PETのテクスチャー解析. 核医学(Web). 2020. 57. Supplement

ｍore...

Patents (2)：

Committee career (5)：

Awards (18)：

2024/10 - 第60回日本医学放射線学会秋季臨床大会医療政策セッション・最優秀賞 FDG-PETを用いた頭頸部癌と肺癌の治療後の活動性;残存病変評価
2024/08 - Mediastinum Outstanding Authors (2024) Imaging of thymic epithelial tumors-a clinical practice review
2024/04 - Gakken秀潤社第29回「画像診断」MVP賞第29回「画像診断」MVP賞
2024/01 - 北米放射線学会 Editor’s Recognition Award for Reviewing with Distinction
2021/11 - 日本核医学会症例検討会優秀賞

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page